Welcome to

 
iNEW
Februay 5–7, 2020
Zurich, Switzerland
 

Exploring Postoperative Decline of Brain Function

Schedule

Wednesday

February 5, 2020
The Vulnerable Brain
Clinics of POD/POCD
08:00-09:45 Session 1:
Exploring postoperative decline
Moderators: H. Jokeit, D. Rüfenacht
08:00 1.1: Why exploring postoperative decline? – The vulnerable brain
(Isabel Wanke)
08:20 1.2: Epidemiology and economics
of postoperative decline
(Reto Stocker)
08:40 1.3: Postoperative decline and
public health
(N.N.)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 2:
Postoperative Decline: from POD to POCD
Moderators: H. Jokeit, R. Stocker
10:30 2.1: From POD to POCD:
terms and concepts
(Victoria Reed)
10:50 2.2: POD, patient safety,
and the anesthesiologist
(Johannes Wacker)
11:10 2.3: Frailty as a predictor of
postoperative decline
(Sacha Beck)
11:30 Discussion
12:15 LUNCH
13:30-15:15 Session 3:
POD/POCD assessment
Moderators: K. Wachter, S. Beck
13:30 3.1: Assessment of Memory and Cognition
(Hennric Jokeit)
13:50 3.2: Assessment of Mood and
Quality of Life
(Katja Cattapan)
14:10 3.3: Neuro Motor Index
Technology - Altoida
(Irene Meier)
14:30 Discussion
15:15 Coffee break
16:00-17:45 Session 4:
Imaging of the aging brain
Moderators: K. Lovblad, I. Wanke
16:00 4.1: Large-scale brain studies
in the ageing population -
an in vivo histology approach
(Bogdan Draganski)
16:20 4.2: Brain volume changes
in normal aging?
(Hans-Jürgen Huppertz)
16:40 4.3 Fully automated quantification of
MR brain scans - Combinostics
(Jyrki Lötjönen)
17:00 Discussion
17:45 End of day 1
Welcome Apéro

Thursday

February 6, 2020
The Aging Brain
Cellular Mechanisms
08:00-09:45 Session 5:
Brain perfusion
Moderators: D. Hasan, K. Lovblad
08:00 5.1: Imaging of brain perfusion
(Karl Lövblad)
08:20 5.2: Perioperative monitoring-Luciole
(Philippe Dro)
08:40 5.3: In silico perfusion and
transport phenomena
(Yiannis Ventikos)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 6:
Brain and Vessel Wall Metabolism
Moderators: M. Hottiger
10:30 6.1: NAD compartimentalisation
regulates intracellular ADP-ribosylation
dynamics during oxidative stress
(Ann-Katrin Hopp)
10:50 6.2: Metabolic conditions
of the vessel wall
(Katrien De Bock)
11:10 6.3: PET imaging of
brain metabolism – Positrigo
(Max Ahnen)
11:30 Discussion
12:15 LUNCH
13:30-15:15 Session 7:
Cellular Aging and Inflammation
Moderators: M. Hottiger, L. Steiner
13:30 7.1: Mitochondrial dysfunction and the inflammatory response
(Anna Csiszar)
13:50 7.2: Concepts of neuroinflammation
(Stergios Tsartsalis)
14:10 7.3: Inflammation of
endothelial cells
(Wei-Lynn Wong)
14:30 Discussion
15:15 Coffee break
16:00-17:45 Session 8:
POD / POCD Prevention Concepts: Preconditioning
Moderators: C. Brenner, J. Fröhlich
16:00 8.1: Crosstalk of metabolism
and inflammation –
preconditioning options
(Michael Hottiger)
16:20 8.2: HBOT preconditioning
(Nayeli Schmutz)
16:40 8.3: Overview of current drug preconditioning
(Luzius Steiner)
17:00 Discussion
17:45 End of day 2
Meeting-Dinner

Friday

February 7, 2020
Care Concepts for Vulnerable
Brain Conditions
08:00-09:45 Session 9:
Drug Preconditioning
Moderators: J. Fröhlich, M. Hottiger
08:00 9.1: Nicotinamide Riboside: Molecular
concepts and clinical experience
(Charles Brenner) – videoconference
08:20 9.2: Metformin: Review of molecular
concepts and clinical experience
(John Fröhlich)
08:40 9.3: Ketamine preconditioning
to prevent delirium
(Frédérique Hovaguimian)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 10:
POD/POCD
Moderators: D. Rüfenacht, S. Beck
10:30 10.1: Pre-interventional POCD risk assessment: the PIPRA concept
(Henry Perschak)
10:50 10.2: CDVC Care Delivery Value Chain
for Postoperative Decline
(Daniel Rüfenacht)
11:10 10.3: The brain at risk: avoiding POCD - a synopsis of current understanding
(David Hasan)
11:30 Discussion
13:00 Conclusion and Farewell

Download schedule


Feel free to get your own copy of the schedule.
Download as PDF

Schedule

Wednesday, February 5, 2020
The Vulnerable Brain
Clinics of POD/POCD
08:00-09:45 Session 1:
Exploring postoperative decline
Moderators: H. Jokeit, D. Rüfenacht
08:00 1.1: Why exploring postoperative decline? – The vulnerable brain
(Isabel Wanke)
08:20 1.2: Epidemiology and economics
of postoperative decline
(Reto Stocker)
08:40 1.3: Postoperative decline and
public health
(N.N.)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 2:
Postoperative Decline: from POD to POCD
Moderators: H. Jokeit, R. Stocker
10:30 2.1: From POD to POCD:
terms and concepts
(Victoria Reed)
10:50 2.2: POD, patient safety,
and the anesthesiologist
(Johannes Wacker)
11:10 2.3: Frailty as a predictor of
postoperative decline
(Sacha Beck)
11:30 Discussion
12:15 LUNCH
13:30-15:15 Session 3:
POD/POCD assessment
Moderators: K. Wachter, S. Beck
13:30 3.1: Assessment of Memory and Cognition
(Hennric Jokeit)
13:50 3.2: Assessment of Mood and
Quality of Life
(Katja Cattapan)
14:10 3.3: Neuro Motor Index
Technology - Altoida
(Irene Meier)
14:30 Discussion
15:15 Coffee break
16:00-17:45 Session 4:
Imaging of the aging brain
Moderators: K. Lovblad, I. Wanke
16:00 4.1: Large-scale brain studies
in the ageing population -
an in vivo histology approach
(Bogdan Draganski)
16:20 4.2: Brain volume changes
in normal aging?
(Hans-Jürgen Huppertz)
16:40 4.3 Fully automated quantification of
MR brain scans - Combinostics
(Jyrki Lötjönen)
17:00 Discussion
17:45 End of day 1
Welcome Apéro
Thursday, February 6, 2020
The Aging Brain
Cellular Mechanisms
08:00-09:45 Session 5:
Brain perfusion
Moderators: D. Hasan, K. Lovblad
08:00 5.1: Imaging of brain perfusion
(Karl Lövblad)
08:20 5.2: Perioperative monitoring-Luciole
(Philippe Dro)
08:40 5.3: In silico perfusion and
transport phenomena
(Yiannis Ventikos)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 6:
Brain and Vessel Wall Metabolism
Moderators: M. Hottiger
10:30 6.1: NAD compartimentalisation
regulates intracellular ADP-ribosylation
dynamics during oxidative stress
(Ann-Katrin Hopp)
10:50 6.2: Metabolic conditions
of the vessel wall
(Katrien De Bock)
11:10 6.3: PET imaging of
brain metabolism – Positrigo
(Max Ahnen)
11:30 Discussion
12:15 LUNCH
13:30-15:15 Session 7:
Cellular Aging and Inflammation
Moderators: M. Hottiger, L. Steiner
13:30 7.1: Mitochondrial dysfunction and the inflammatory response
(Anna Csiszar)
13:50 7.2: Concepts of neuroinflammation
(Stergios Tsartsalis)
14:10 7.3: Inflammation of
endothelial cells
(Wei-Lynn Wong)
14:30 Discussion
15:15 Coffee break
16:00-17:45 Session 8:
POD / POCD Prevention Concepts: Preconditioning
Moderators: C. Brenner, J. Fröhlich
16:00 8.1: Crosstalk of metabolism
and inflammation –
preconditioning options
(Michael Hottiger)
16:20 8.2: HBOT preconditioning
(Nayeli Schmutz)
16:40 8.3: Overview of current drug preconditioning
(Luzius Steiner)
17:00 Discussion
17:45 End of day 2
Meeting-Dinner
Friday, February 7, 2020
Care Concepts for Vulnerable
Brain Conditions
08:00-09:45 Session 9:
Drug Preconditioning
Moderators: J. Fröhlich, M. Hottiger
08:00 9.1: Nicotinamide Riboside: Molecular
concepts and clinical experience
(Charles Brenner) – videoconference
08:20 9.2: Metformin: Review of molecular
concepts and clinical experience
(John Fröhlich)
08:40 9.3: Ketamine preconditioning
to prevent delirium
(Frédérique Hovaguimian)
09:00 Discussion
09:45 Coffee break
10:30-12:15 Session 10:
POD/POCD
Moderators: D. Rüfenacht, S. Beck
10:30 10.1: Pre-interventional POCD risk assessment: the PIPRA concept
(Henry Perschak)
10:50 10.2: CDVC Care Delivery Value Chain
for Postoperative Decline
(Daniel Rüfenacht)
11:10 10.3: The brain at risk: avoiding POCD - a synopsis of current understanding
(David Hasan)
11:30 Discussion
13:00 Conclusion and Farewell

Download schedule


Feel free to get your own copy of the schedule.
Download as PDF

A collaboration of